AdvocureNF2 Inc / Could Restore Hearing - Draper Laboratory / Advocure NF2 Inc. / forGroup / Wicab Inc. / Advocure Online Newsletter Advocure NF2 Inc. / Cornerstone Pharmaceuticals Inc. / Cornerstone Pharma / PRO Working Group / Johnson & Johnson / Accelerating Medicines Partnership / DONATE Facebook RSS Feed Twitter Advocure NF2 Inc. / Yale University Open Data Access Project / /
Country
United Kingdom / United States / /
Currency
USD / / /
Event
FDA Phase / Product Issues / Funding / /
Facility
Georgetown University Medical Center / University of Central Florida NF2 Drug Discovery / University of Alabama / University of Pittsburgh Medical Center / National Institute / Lighthouse International / University School / Massachusetts General Hospital / Carnegie Mellon University / University Hospitals Case Medical Center / Lombardi Comprehensive Cancer Center / Massachusetts Institute of Technology / University of Birmingham / Ear/Massachusetts General Hospital / /
IndustryTerm
high-tech goggles / tinnitus treatment device / pharmaceutical industry / exterior hardware / intracochlear drug delivery device / chemical structures / Brain Tumor Treatment / gene products / diagnostic tools / treatment of a brain tumor / high-tech glasses / pharmaceutical / model systems / taste food / drug delivery device / /
MedicalCondition
X-Ray Glasses Help Surgeons See Cancer / allergies / ependymomas / recurrent glioma / recurrent glioblastoma / sickle cell anaemia Diseases / glioblastoma cells / original tumor / human schwannoma primary cells / NF2-deficient schwannoma / vestibular schwannoma growth / melanoma / Local tumor / NF2 tumors / newly diagnosed neurofibromatosis / disorder / human schwannomas / rare genetic disorder neurofibromatosis / vestibular schwannoma removal / vestibular schwannoma surgery / brain tumour / brain tumor / glioblastoma / Vestibular Schwannomas/Acoustic Neuromas / tumor / schwannoma pathogenesis / cancer / neurofibromatosis type / innovative / high-impact neurofibromatosis / tumors / emergent recurrent tumors / genetic diseases / Are Giving Ourselves Cancer / neurofibromatosis / benign tumors / migraine headaches / vestibular schwannoma / vestibular schwannomas / personalized cancer / Depression / tinnitus / tumours / NF2 schwannomas / Neurofibromatosis Type 2 / headaches / radiation necrosis / obvious injury / NF2-deficient schwannoma cell lines / low-grade gliomas / heart disease / Intramedullary ependymomas / meningiomas / human schwannoma cell culture using Cellular Reprogramming technology / rare and benign tumors / rare disorder / cystic fibrosis / asymmetric hearing loss / schwannoma / hearing loss / hearing impairment / individual’s specific tumor / Treat Rare Genetic Diseases / necrosis / disease / familial autosomal dominant intramedullary ependymoma / larger tumor / One Cancer Test Find Unrelated Tumors / atypical meningioma / NF2-related tumors / rare disease / young tumors / nonmalignant brain tumors / Pain / schwannomas / sporadic vestibular schwannomas / lung cancer / human disease / /
NF Registry’s mission / Georgetown University Medical Center / American Brain Tumor Association / Other Communication Disorders / Lombardi Comprehensive Cancer Center / Liason / Massachusetts Institute of Technology / University of Leeds / University of Central Florida NF2 Drug Discovery / Medicare / UNC Department of Pharmacology / University of Pittsburgh / Lab on a Chip Features Drug Delivery Device / FDA / Carnegie Mellon University / Wells Center / University Hospitals Case Medical Center / Pittsburgh Medical Center / Brain Tumour Charity / Harvard Medical School / National Institute of Health / Department of Defense Neurofibromatosis Research Program / Massachusetts General Hospital / Massachusetts Eye and Ear/Massachusetts General Hospital / Public Charity / Washington University School of Medicine in St. Louis / Yale University / University of Birmingham / federal government / US Food and Drug Administration / University of Alabama / National Institute on Deafness / Children’s Tumor Foundation / /
Person
Lisa / Tessa Kohnhorst / Renee Stebar / Michael Harris / Cristina Fernandez-Valle / Chunling Yi / Robert Bellin / Gary Johnson / John / Cutting Edge / Erin Manth / Ravi Bellamkonda / Fernandez-Vallue / Sheng Chang / Leah Manth / Andrew Peet / Richard Hogle / Keith Kohnhorst / Ryan Fields / D. Bradley Welling / Roland Thoms / Giovannini / /
Position
neurosurgeon / professor and chair / Chief / engineer / Professor / surgeon / associate professor / Board member / Ear/Mass General Otolaryngology Chief / Scientist / messenger / leader / professor of biology / Chair / /
Product
Drosophila / HMS / schwannoma cell lines / normal Schwann cells / schwannoma / Discovery / /
ProgrammingLanguage
DC / /
ProvinceOrState
Ohio / Alabama / California / Massachusetts / /
PublishedMedium
Nature Genetics / /
Region
Northeast Ohio / Central Florida / /
Technology
radiation / X-Ray / stem cells / drug screening / drug delivery / drug discovery / Cellular Reprogramming technology / Lab on a Chip / chemotherapy / Spectroscopy / Ultrasound / MRI / gene therapy / laser / human schwannoma cell culture using Cellular Reprogramming technology / /
Spring[removed]NF2 Compass A Quarterly Advocure Online Newsletter Advocure NF2 Inc. is a Working Advocacy Group, Liason, and 501 (c)(3)